{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T02:38:23Z","timestamp":1774319903672,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.drugalcdep.2004.10.002","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T22:49:39Z","timestamp":1103150979000},"page":"91-99","source":"Crossref","is-referenced-by-count":39,"title":["Comparison of the behavioral effects of gamma-hydroxybutyric acid (GHB) and its 4-methyl-substituted analog, gamma-hydroxyvaleric acid (GHV)"],"prefix":"10.1016","volume":"78","author":[{"given":"Lawrence P.","family":"Carter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok K.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jason","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maharaj K.","family":"Ticku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Coop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Koek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles P.","family":"France","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2004.10.002_bib1","doi-asserted-by":"crossref","unstructured":"Baker, L.E., Pynnonen, D., Poling, A., 2004. Influence of reinforcer type and route of administration on gamma-hydroxybutyrate discrimination in rats. Psychpharmacol. 174, 220\u2013227.","DOI":"10.1007\/s00213-003-1744-z"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/jm00400a001","article-title":"Analogues of gamma-hydroxybutyric acid. Synthesis and binding studies","volume":"31","author":"Bourguignon","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib3","first-page":"115","article-title":"The cardiovascular effects of gamma-hydroxybutyrate following hemorrhage","volume":"38","author":"Boyd","year":"1992","journal-title":"Circ. Shock"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0376-8716(02)00340-X","article-title":"Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study","volume":"70","author":"Caputo","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0014-2999(01)01334-6","article-title":"Role of GABA(B) receptors in the sedative\/hypnotic effect of gamma-hydroxybutyric acid","volume":"428","author":"Carai","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(02)01502-9","article-title":"Central effects of 1,4-butanediol are mediated by GABA(B) receptors via its conversion into gamma-hydroxybutyric acid","volume":"441","author":"Carai","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1124\/jpet.102.047860","article-title":"The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies","volume":"305","author":"Carter","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/jpet.103.062950","article-title":"The discriminative stimulus effects of gamma-hydroxybutyrate (GHB) and related compounds in rats discriminating baclofen or diazepam: the role of GABAB and GABAA receptors","volume":"309","author":"Carter","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0306-9877(96)90157-7","article-title":"What is the role of the gamma-hydroxybutyrate receptor?","volume":"47","author":"Cash","year":"1996","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1046\/j.1471-4159.2003.02037.x","article-title":"Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative\/hypnotic effect of gamma-hydroxybutyric acid","volume":"87","author":"Castelli","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0031-9384(98)00062-6","article-title":"Involvement of GABA(A) and GABA(B) receptors in the mediation of discriminative stimulus effects of gamma-hydroxybutyric acid","volume":"64","author":"Colombo","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0376-8716(01)00163-6","article-title":"GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings","volume":"65","author":"Cousins","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.pbb.2004.01.009","article-title":"Comparison of the actions of gamma-butyrolactone and 1, 4-butanediol in Swiss-Webster mice","volume":"77","author":"de Fiebre","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0376-8716(02)00017-0","article-title":"GHB use among Australians: characteristics, use patterns and associated harm","volume":"67","author":"Degenhardt","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-2952(75)90130-6","article-title":"Metabolism of (1\u201314C)gamma-hydroxybutyric acid by rat brain after intraventricular injection","volume":"24","author":"Doherty","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0740-5472(02)00267-2","article-title":"The effects and consequences of selected club drugs","volume":"23","author":"Freese","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1592\/phco.23.10.1205.32756","article-title":"From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy","volume":"23","author":"Fuller","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1471-4159.1977.tb10670.x","article-title":"Kinetics of in vivo conversion of gamma-[3H]aminobutyric acid to gamma-[3H]hydroxybutyric acid by rat brain","volume":"28","author":"Gold","year":"1977","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0006-2952(96)00664-8","article-title":"Effect of gamma-hydroxybutyrate on central dopamine release in vivo. A microdialysis study in awake and anesthetized animals","volume":"53","author":"Howard","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1749-6632.2002.tb04186.x","article-title":"Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB","volume":"965","author":"Itzhak","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1124\/jpet.103.056093","article-title":"Discriminative stimulus effects of {gamma}-hydroxybutyrate (GHB) in pigeons: role of diazepam-sensitive and -insensitive GABAA receptors, and of GABAB receptors","volume":"308","author":"Koek","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/sleep\/13.1.24","article-title":"The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms","volume":"13","author":"Lapierre","year":"1990","journal-title":"Sleep"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0379-0738(02)00424-3","article-title":"Intoxication due to 1, 4-butanediol","volume":"133","author":"Lora-Tamayo","year":"2003","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.STR.11.3.271","article-title":"Effects of gamma-hydroxybutyrate and gamma-butyrolactone on cerebral energy metabolism during exposure and recovery from hypoxemia-oligemia","volume":"11","author":"MacMillan","year":"1980","journal-title":"Stroke"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib25","first-page":"261","article-title":"Gamma-hydroxybutyrate is a GABAB receptor agonist that increases a potassium conductance in rat ventral tegmental dopamine neurons","volume":"287","author":"Madden","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","article-title":"The gamma-hydroxybutyrate signalling system in brain: organization and functional implications","volume":"51","author":"Maitre","year":"1997","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib27","first-page":"273","article-title":"The effects of gamma-hydroxybutyrate on sleep","volume":"12","author":"Mamelak","year":"1977","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0924-977X(97)00087-4","article-title":"Intravenous self-administration of gamma-hydroxybutyric acid in drug-naive mice","volume":"8","author":"Martellotta","year":"1998","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050312","article-title":"Rewarding properties of gamma-hydroxybutyric acid: an evaluation through place preference paradigm","volume":"132","author":"Martellotta","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib30","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1553-2712.2002.tb02154.x","article-title":"Gamma hydroxybutyric acid (GHB) intoxication","volume":"9","author":"Mason","year":"2002","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(96)00916-8","article-title":"Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist","volume":"321","author":"Mathivet","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib32","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/0006-2952(72)90301-2","article-title":"Conversion of 1, 4-butanediol to gamma-hydroxybutyric acid in rat brain and in peripheral tissue","volume":"21","author":"Maxwell","year":"1972","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.drugalcdep.2004.01.012","article-title":"Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review","volume":"75","author":"McDonough","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib34","first-page":"1148","article-title":"Binding characteristics of the gamma-hydroxybutyric acid receptor antagonist [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid in the rat brain","volume":"299","author":"Mehta","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0028-3908(87)90108-0","article-title":"Baclofen induces catatonia in rats","volume":"26","author":"Mehta","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(00)00191-5","article-title":"GHB: a new and novel drug of abuse","volume":"63","author":"Nicholson","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0006-8993(03)03252-9","article-title":"Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage","volume":"986","author":"Ottani","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/alcalc\/34.1.15","article-title":"The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies","volume":"34","author":"Poldrugo","year":"1999","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0028-3908(84)90226-0","article-title":"1,4 Butanediol, gamma-hydroxybutyric acid and ethanol: relationships and interactions","volume":"23","author":"Poldrugo","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1749-6632.2002.tb04187.x","article-title":"Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice","volume":"965","author":"Quang","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib41","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0006-2952(66)90045-1","article-title":"Gamma-butyrolactone and gamma-hydroxybutyric acid-1. Distribution and metabolism","volume":"15","author":"Roth","year":"1966","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejphar.2003.10.045","article-title":"Neuroleptic-like effects of gamma-hydroxybutyrate: interactions with haloperidol and dizocilpine","volume":"483","author":"Sevak","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0028-3908(91)90199-L","article-title":"The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges","volume":"30","author":"Snead","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib44","unstructured":"United States Department of Justice, Drug Enforcement Agency, 2003. Microgram Bull. 36, 98\u2013102."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","article-title":"From the street to the brain: neurobiology of the recreational drug gamma-hydroxybutyric acid","volume":"25","author":"Wong","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1124\/jpet.102.046797","article-title":"A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand","volume":"305","author":"Wu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2004.10.002_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0014-2999(92)94839-N","article-title":"gamma-Hydroxybutyrate depresses monosynaptic excitatory and inhibitory postsynaptic potentials in rat hippocampal slices","volume":"223","author":"Xie","year":"1992","journal-title":"Eur. J. Pharmacol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871604002807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871604002807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T09:24:29Z","timestamp":1548926669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871604002807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0376871604002807"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2004.10.002","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}